What to Watch With COCO Stock in 2026

Vita Coco has delivered strong top-line momentum with 2024 total revenues of $516 million, net sales up 24% through the first three quarters to $482 million and Q3 net sales rising 37% to $182 million. Management is guiding 2025 net sales of $580–$595 million and expects full-year gross margins of about 36%, while the broader coconut-water market is projected to grow from $4.43 billion in 2024 to $11.43 billion by 2030. The stock has outperformed substantially (≈55% YTD, 290% over five years) and currently trades at roughly 47x earnings, so continued high growth and margin resilience — amid competition from PepsiCo and impacts from tariffs/cost pressures — will be required to justify the valuation.

Analysis

Market structure: Vita Coco (COCO) sits in a category with 17% CAGR market growth (US$4.43B→US$11.43B by 2030), so demand tailwinds exist but incumbents like PepsiCo (PEP) can scale faster via distribution economics. COCO’s 2024 revenue of $516M and guidance $580–595M for 2025 imply +12–15% growth, below category CAGR and well short of the ~20%+ growth implied by a 47x earnings multiple, making market-share gains the key variable.

Risk assessment: Immediate risks (days–weeks) include earnings/guide misses and tariff announcements that can swing sentiment; short-term (3–6 months) risks are margin compression if COGS rise above guidance (gross margin <34% vs guided 36%). Tail risks (low prob, high impact) include supply shocks in SE Asia, a major food-safety recall, or a scaled PEP national launch compressing pricing — any of which could halve consensus EPS. Hidden dependency: valuation sensitivity — a 5–10% revenue miss could drop implied growth expectations and compress multiple by 20–40%.

Trade implications: If you expect COCO to hit guidance, asymmetric long view via size-limited exposure is reasonable; if not, volatility trades or pair trades versus PEP are preferable. Options: 3–6 month put spreads to hedge downside or sell OTM call premium on funded positions; liquidity is adequate for front-month options but implied vol will reprice around results.

Contrarian angles: The consensus assumes COCO must maintain high growth; that’s debatable because share gains can come from margin expansion (innovation, SKU mix) rather than pure top-line. If COCO can hold 36%+ gross margin and reaccelerate to >18% growth in 2026, the current multiple is supportable — the market may be under-pricing this recovery option, but it is also pricing in significant execution risk.

Key Decisions for Investors

• Establish a tactical 2–3% long position in COCO (size of total equity portfolio) only on a pullback of ≥10% from current levels; target exit at +30–40% or if COCO reports FY2025 net sales < $575M or gross margin < 34%.
• If concerned about downside, buy 3–6 month COCO put spreads (e.g., -15%/ -30% strikes) sized to cover 1–2% portfolio risk; this caps premium while protecting against a 20–40% drawdown around earnings/guide events.
• Execute a relative-value pair: long PEP (1–2%) vs short COCO (1%) over 6–12 months — thesis: PEP’s diversification and scale will outperform COCO if category pricing / distribution intensifies; tighten if COCO posts >15% y/y rev growth with stable margins.
• Watch three triggers in next 30–60 days before increasing exposure: (1) Q4/2025 sales outside $580–595M, (2) gross margin deviation >200bps from 36%, (3) any major tariff or supply-disruption announcement in producing countries — act immediately if any occur.